By Ryan Davis (July 2, 2019, 9:40 PM EDT) -- The just-concluded U.S. Supreme Court term was quiet on the patent front, with only two decisions, but pending cases could put notable patent issues before the court in the coming months. Here's a look at the patent rulings from the last term and a preview of the next one.
Helsinn Healthcare SA v. Teva Pharmaceuticals USA Inc.
This January decision rejected an argument that changes the America Invents Act made to the language governing the on-sale bar rule undid precedent that sales of a product that are secret can be prior art that renders a patent invalid if they take place...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!